Catalyst Wire Dossier Catalyst Wire Dossier

Topical R333

· Rigel Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Topical R333, covering 2016-06-08 to 2016-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions [Phase 2]

See pricing